{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:58:51Z","timestamp":1793761131720,"version":"4.6.1"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-024-02512-1","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T02:07:06Z","timestamp":1734314826000},"page":"785-798","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["PCOS - the many faces of a disorder in women and men"],"prefix":"10.1007","volume":"48","author":[{"given":"Naz Guleray","family":"Lafci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-7662","authenticated-orcid":false,"given":"Bulent Okan","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"issue":"2","key":"2512_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","volume":"29","author":"IF Stein","year":"1935","unstructured":"Stein IF, Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29(2):181\u2013191. https:\/\/doi.org\/10.1016\/S0002-9378(15)30642-6","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"2512_CR2","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31(12):2841\u20132855. https:\/\/doi.org\/10.1093\/humrep\/dew218","journal-title":"Hum Reprod"},{"key":"2512_CR3","doi-asserted-by":"publisher","unstructured":"Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO (2016) Polycystic ovary syndrome. Nat Rev Dis Primers 216057. https:\/\/doi.org\/10.1038\/nrdp.2016.57","DOI":"10.1038\/nrdp.2016.57"},{"issue":"3","key":"2512_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40618-014-0215-1","volume":"38","author":"D Macut","year":"2015","unstructured":"Macut D, Anti\u0107 IB, Bjeki\u0107-Macut J (2015) Cardiovascular risk factors and events in women with androgen excess. J Endocrinol Invest 38(3):295\u2013301. https:\/\/doi.org\/10.1007\/s40618-014-0215-1","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2512_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-016-0173-x","volume":"14","author":"V De Leo","year":"2016","unstructured":"De Leo V, Musacchio M, Cappelli V, Massaro M, Morgante G, Petraglia F (2016) Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol 14(1):1\u201317. https:\/\/doi.org\/10.1186\/s12958-016-0173-x","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"2512_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.rbmo.2020.04.024","volume":"41","author":"SH Oguz","year":"2020","unstructured":"Oguz SH, \u0130dilman I, Helvaci N, Guzelce EC, Eyupoglu D, Karcaaltincaba M et al (2020) Tissue fat quantification by magnetic resonance imaging: proton density fat fraction in polycystic ovary syndrome. Reprod Biomed Online 41(2):329\u2013334. https:\/\/doi.org\/10.1016\/j.rbmo.2020.04.024","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"2512_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/liv.14279","volume":"40","author":"M Sarkar","year":"2020","unstructured":"Sarkar M, Terrault N, Chan W, Cedars MI, Huddleston HG, Duwaerts CC et al (2020) Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis. Liver Int 40(2):355\u2013359. https:\/\/doi.org\/10.1111\/liv.14279","journal-title":"Liver Int"},{"issue":"11","key":"2512_CR8","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W et al (2006) Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 91(11):4237\u20134245. https:\/\/doi.org\/10.1210\/jc.2006-0178","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2512_CR9","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1093\/humrep\/der338","volume":"26","author":"N Cinar","year":"2011","unstructured":"Cinar N, Kizilarslanoglu MC, Harmanci A, Aksoy DY, Bozdag G, Demir B et al (2011) Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod 26(12):3339\u20133345. https:\/\/doi.org\/10.1093\/humrep\/der338","journal-title":"Hum Reprod"},{"issue":"5","key":"2512_CR10","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/humrep\/dex044","volume":"32","author":"LG Cooney","year":"2017","unstructured":"Cooney LG, Lee I, Sammel MD, Dokras A (2017) High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 32(5):1075\u20131091. https:\/\/doi.org\/10.1093\/humrep\/dex044","journal-title":"Hum Reprod"},{"issue":"1","key":"2512_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/clinem\/dgab640","volume":"107","author":"D Shan","year":"2022","unstructured":"Shan D, Han J, Cai Y, Zou L, Xu L, Shen Y (2022) Reproductive health in first-degree relatives of patients with polycystic ovary syndrome: a review and meta-analysis. J Clin Endocrinol Metab 107(1):273\u2013295. https:\/\/doi.org\/10.1210\/clinem\/dgab640","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2512_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.fertnstert.2017.10.018","volume":"109","author":"B Yilmaz","year":"2018","unstructured":"Yilmaz B, Vellanki P, Ata B, Yildiz BO (2018) Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Ster 109(2):356\u2013364e32. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.10.018","journal-title":"Fertil Ster"},{"issue":"3","key":"2512_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.fertnstert.2018.04.024","volume":"110","author":"B Yilmaz","year":"2018","unstructured":"Yilmaz B, Vellanki P, Ata B, Yildiz BO (2018) Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Ster 110(3):523\u2013533e14. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.04.024","journal-title":"Fertil Ster"},{"issue":"3","key":"2512_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/cen.14558","volume":"97","author":"N Helvaci","year":"2022","unstructured":"Helvaci N, Yildiz BO (2022) The impact of ageing and menopause in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 97(3):371\u2013382. https:\/\/doi.org\/10.1111\/cen.14558","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2512_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coemr.2020.01.005","volume":"12","author":"E Vanky","year":"2020","unstructured":"Vanky E, L\u00f8vvik TS (2020) Polycystic ovary syndrome and pregnancy\u2013 from a clinical perspective. Curr Opin Endocr Metab Res 12:8\u201313. https:\/\/doi.org\/10.1016\/j.coemr.2020.01.005","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"6","key":"2512_CR16","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.fertnstert.2019.03.015","volume":"111","author":"E Vanky","year":"2019","unstructured":"Vanky E, Engen Hanem LG, Abbott DH (2019) Children born to women with polycystic ovary syndrome-short- and long-term impacts on health and development. Fertil Ster 111(6):1065\u20131075. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.03.015","journal-title":"Fertil Ster"},{"issue":"3","key":"2512_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/S2040174417001118","volume":"9","author":"ES Barrett","year":"2018","unstructured":"Barrett ES, Hoeger KM, Sathyanarayana S, Abbott DH, Redmon JB, Nguyen RH et al (2018) Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure. J Dev Orig Health Dis 9(3):307\u2013314. https:\/\/doi.org\/10.1017\/S2040174417001118","journal-title":"J Dev Orig Health Dis"},{"key":"2512_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-017-0282-1","volume":"15","author":"R Homburg","year":"2017","unstructured":"Homburg R, Gudi A, Shah A, Layton M A (2017) A novel method to demonstrate that pregnant women with polycystic ovary syndrome hyper-expose their fetus to androgens as a possible stepping stone for the developmental theory of PCOS. A pilot study. Reprod Biol Endocrinol 15:1\u20134. https:\/\/doi.org\/10.1186\/s12958-017-0282-1","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"2512_CR19","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/aogs.13200","volume":"96","author":"SK Finnbogad\u00f3ttir","year":"2017","unstructured":"Finnbogad\u00f3ttir SK, Glintborg D, Jensen TK, Kyhl HB, Nohr EA, Andersen M (2017) Insulin resistance in pregnant women with and without polycystic ovary syndrome, and measures of body composition in offspring at birth and three years of age. Acta Obstet Gynecol Scand 96(11):1307\u20131314. https:\/\/doi.org\/10.1111\/aogs.13200","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"2512_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S2352-4642(18)30385-7","volume":"3","author":"LGE Hanem","year":"2019","unstructured":"Hanem LGE, Salvesen \u00d8, Juliusson PB, Carlsen SM, Nossum MCF, Vaage M\u00d8 et al (2019) Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5\u201310 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc Health 3(3):166\u2013174. https:\/\/doi.org\/10.1016\/S2352-4642(18)30385-7","journal-title":"Lancet Child Adolesc Health"},{"issue":"9","key":"2512_CR21","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/jech-2017-210004","volume":"72","author":"GA Bell","year":"2018","unstructured":"Bell GA, Sundaram R, Mumford SL, Park H, Broadney M, Mills JL et al (2018) Maternal polycystic ovarian syndrome and offspring growth: the Upstate KIDS Study. J Epidemiol Community Health 72(9):852\u2013855. https:\/\/doi.org\/10.1136\/jech-2017-210004","journal-title":"J Epidemiol Community Health"},{"key":"2512_CR22","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1177\/1933719117749761","volume":"25","author":"MA de Wilde","year":"2018","unstructured":"de Wilde MA, Eising JB, Gunning MN, Koster MP, Evelein AM, Dalmeijer GW et al (2018) Cardiovascular and metabolic health of 74 children from women previously diagnosed with polycystic ovary syndrome in comparison with a population-based reference cohort. Reprod Sci 25:1492\u20131500. https:\/\/doi.org\/10.1177\/1933719117749761","journal-title":"Reprod Sci"},{"issue":"8","key":"2512_CR23","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1210\/jc.2005-2693","volume":"91","author":"T Sir-Petermann","year":"2006","unstructured":"Sir-Petermann T, Codner E, Maliqueo M, Echiburu B, Hitschfeld C, Crisosto N et al (2006) Increased anti-mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 91(8):3105\u20133109. https:\/\/doi.org\/10.1210\/jc.2005-2693","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2512_CR24","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1210\/jc.2008-2836","volume":"94","author":"T Sir-Petermann","year":"2009","unstructured":"Sir-Petermann T, Codner E, P\u00e9rez V, Echibur\u00fa B, Maliqueo M, Ladron de Guevara A et al (2009) Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 94(6):1923\u20131930. https:\/\/doi.org\/10.1210\/jc.2008-2836","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2512_CR25","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1210\/jc.2007-0267","volume":"92","author":"N Crisosto","year":"2007","unstructured":"Crisosto N, Codner E, Maliqueo M, Echiburu B, Sanchez F, Cassorla F et al (2007) Anti-mullerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 92(7):2739\u20132743. https:\/\/doi.org\/10.1210\/jc.2007-0267","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2512_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1210\/jc.2016-2707","volume":"102","author":"RS Legro","year":"2017","unstructured":"Legro RS, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Brindle E et al (2017) Normal pubertal development in daughters of women with PCOS: a controlled study. J Clin Endocrinol Metab 102(1):122\u2013131. https:\/\/doi.org\/10.1210\/jc.2016-2707","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2512_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/1933719111424444","volume":"19","author":"T Sir-Petermann","year":"2012","unstructured":"Sir-Petermann T, Guevara ALd, Codner E, Preisler J, Crisosto N, Echibur\u00fa B et al (2012) Relationship between anti-M\u00fcllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome. Reprod Sci 19(4):383\u2013390. https:\/\/doi.org\/10.1177\/1933719111424444","journal-title":"Reprod Sci"},{"issue":"9","key":"2512_CR28","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1210\/jc.2008-0255","volume":"93","author":"SE Recabarren","year":"2008","unstructured":"Recabarren SE, Sir-Petermann T, Rios R, Maliqueo M, Echiburu B, Smith R et al (2008) Pituitary and testicular function in sons of women with polycystic ovary syndrome from infancy to adulthood. J Clin Endocrinol Metab 93(9):3318\u20133324. https:\/\/doi.org\/10.1210\/jc.2008-0255","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2512_CR29","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1530\/EC-17-0218","volume":"6","author":"N Crisosto","year":"2017","unstructured":"Crisosto N, Echibur\u00fa B, Maliqueo M, Luchsinger M, Rojas P, Recabarren S et al (2017) Reproductive and metabolic features during puberty in sons of women with polycystic ovary syndrome. Endocr Connect 6(8):607\u2013613. https:\/\/doi.org\/10.1530\/EC-17-0218","journal-title":"Endocr Connect"},{"issue":"5","key":"2512_CR30","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1210\/jc.2007-2256","volume":"93","author":"SE Recabarren","year":"2008","unstructured":"Recabarren SE, Smith R, Rios R, Maliqueo M, Echiburu B, Codner E et al (2008) Metabolic profile in sons of women with polycystic ovary syndrome. J Clin Endocrinol Metab 93(5):1820\u20131826. https:\/\/doi.org\/10.1210\/jc.2007-2256","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2512_CR31","doi-asserted-by":"publisher","first-page":"101035","DOI":"10.1016\/j.xcrm.2023.101035","volume":"4","author":"S Risal","year":"2023","unstructured":"Risal S, Li C, Luo Q, Fornes R, Lu H, Eriksson G et al (2023) Transgenerational transmission of reproductive and metabolic dysfunction in the male progeny of polycystic ovary syndrome. Cell Rep Med 4(5):101035. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101035","journal-title":"Cell Rep Med"},{"issue":"5","key":"2512_CR32","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1210\/jcem.87.5.8387","volume":"87","author":"RS Legro","year":"2002","unstructured":"Legro RS, Kunselman AR, Demers L, Wang SC, Bentley-Lewis R, Dunaif A (2002) Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. J Clin Endocrinol Metab 87(5):2134\u20132138. https:\/\/doi.org\/10.1210\/jcem.87.5.8387","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2512_CR33","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1210\/jc.2002-021499","volume":"88","author":"BO Yildiz","year":"2003","unstructured":"Yildiz BO, Yarali H, Oguz H, Bayraktar M (2003) Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88(5):2031\u20132036. https:\/\/doi.org\/10.1210\/jc.2002-021499","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2512_CR34","doi-asserted-by":"publisher","first-page":"100844","DOI":"10.1016\/j.xcrm.2022.100844","volume":"3","author":"M Elgart","year":"2022","unstructured":"Elgart M, Goodman MO, Isasi C, Chen H, Morrison AC, de Vries PS et al (2022) Correlations between complex human phenotypes vary by genetic background, gender, and environment. Cell Rep Med 3(12):100844. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100844","journal-title":"Cell Rep Med"},{"issue":"12","key":"2512_CR35","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nrg2415","volume":"9","author":"C Ober","year":"2008","unstructured":"Ober C, Loisel DA, Gilad Y (2008) Sex-specific genetic architecture of human disease. Nat Rev Genet 9(12):911\u2013922. https:\/\/doi.org\/10.1038\/nrg2415","journal-title":"Nat Rev Genet"},{"issue":"6509","key":"2512_CR36","doi-asserted-by":"publisher","first-page":"eaba3066","DOI":"10.1126\/science.aba3066","volume":"369","author":"M Oliva","year":"2020","unstructured":"Oliva M, Mu\u00f1oz-Aguirre M, Kim-Hellmuth S, Wucher V, Gewirtz AD, Cotter DJ et al (2020) The impact of sex on gene expression across human tissues. Science 369(6509):eaba3066. https:\/\/doi.org\/10.1126\/science.aba3066","journal-title":"Science"},{"issue":"3","key":"2512_CR37","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.mehy.2006.03.057","volume":"68","author":"R Kurzrock","year":"2007","unstructured":"Kurzrock R, Cohen PR (2007) Polycystic ovary syndrome in men: Stein\u2013Leventhal syndrome revisited. Med Hypotheses 68(3):480\u2013483. https:\/\/doi.org\/10.1016\/j.mehy.2006.03.057","journal-title":"Med Hypotheses"},{"issue":"12","key":"2512_CR38","doi-asserted-by":"publisher","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","volume":"14","author":"F Day","year":"2018","unstructured":"Day F, Karaderi T, Jones MR, Meun C, He C, Drong A et al (2018) Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet 14(12):e1007813. https:\/\/doi.org\/10.1371\/journal.pgen.1007813","journal-title":"PLoS Genet"},{"issue":"3","key":"2512_CR39","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0002-9378(15)33704-2","volume":"100","author":"HE Cooper","year":"1968","unstructured":"Cooper HE, Spellacy W, Prem K, Cohen W (1968) Hereditary factors in the Stein-Leventhal syndrome. Am J Obstet Gynecol 100(3):371\u2013387","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2512_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/09513599709152521","volume":"11","author":"S Jahanfar","year":"1997","unstructured":"Jahanfar S, Eden J, Nguyen T, Wang X, Wilcken D (1997) A twin study of polycystic ovary syndrome and lipids. Gynecol Endocrinol 11(2):111\u2013117. https:\/\/doi.org\/10.3109\/09513599709152521","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"2512_CR41","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0015-0282(16)57412-3","volume":"63","author":"S Jahanfar","year":"1995","unstructured":"Jahanfar S, Eden JA, Warren P, Sepp\u00e4l\u00e4 M, Nguyen TV (1995) A twin study of polycystic ovary syndrome. Fertil Ster 63(3):478\u2013486. https:\/\/doi.org\/10.1016\/S0015-0282(16)57412-3","journal-title":"Fertil Ster"},{"issue":"6","key":"2512_CR42","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2005-1494","volume":"91","author":"J Vink","year":"2006","unstructured":"Vink J, Sadrzadeh S, Lambalk C, Boomsma D (2006) Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 91(6):2100\u20132104. https:\/\/doi.org\/10.1210\/jc.2005-1494","journal-title":"J Clin Endocrinol Metab"},{"key":"2512_CR43","doi-asserted-by":"publisher","unstructured":"Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ et al (1999) Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc. Natl. Acad. Sci. U.S.A 96(15):8573\u20138578. https:\/\/doi.org\/10.1073\/pnas.96.15.8573","DOI":"10.1073\/pnas.96.15.8573"},{"issue":"1","key":"2512_CR44","doi-asserted-by":"publisher","first-page":"E182","DOI":"10.1210\/jc.2014-2689","volume":"100","author":"MA Brower","year":"2015","unstructured":"Brower MA, Jones MR, Rotter JI, Krauss RM, Legro RS, Azziz R et al (2015) Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals. J Clin Endocrinol Metab 100(1):E182\u2013E186. https:\/\/doi.org\/10.1210\/jc.2014-2689","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2512_CR45","doi-asserted-by":"publisher","first-page":"42000","DOI":"10.1038\/srep42000","volume":"7","author":"Y Peng","year":"2017","unstructured":"Peng Y, Zhang W, Yang P, Tian Y, Su S, Zhang C et al (2017) ERBB4 confers risk for polycystic ovary syndrome in Han Chinese. Sci Rep 7(1):42000. https:\/\/doi.org\/10.1038\/srep42000","journal-title":"Sci Rep"},{"issue":"5","key":"2512_CR46","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1210\/jc.2015-3776","volume":"101","author":"Y Tian","year":"2016","unstructured":"Tian Y, Zhao H, Chen H, Peng Y, Cui L, Du Y et al (2016) Variants in FSHB are associated with polycystic ovary syndrome and luteinizing hormone level in Han Chinese women. J Clin Endocrinol Metab 101(5):2178\u20132184. https:\/\/doi.org\/10.1210\/jc.2015-3776","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2512_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng.732","volume":"43","author":"Z-J Chen","year":"2011","unstructured":"Chen Z-J, Zhao H, He L, Shi Y, Qin Y, Shi Y et al (2011) Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16. 3, 2p21 and 9q33.3. Nat Genet 43(1):55\u201359. https:\/\/doi.org\/10.1038\/ng.732","journal-title":"Nat Genet"},{"issue":"6","key":"2512_CR48","doi-asserted-by":"publisher","first-page":"e1003132","DOI":"10.1371\/journal.pmed.1003132","volume":"17","author":"M Dapas","year":"2020","unstructured":"Dapas M, Lin FT, Nadkarni GN, Sisk R, Legro RS, Urbanek M et al (2020) Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis. PLoS Med 17(6):e1003132. https:\/\/doi.org\/10.1371\/journal.pmed.1003132","journal-title":"PLoS Med"},{"issue":"1","key":"2512_CR49","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.1038\/ncomms9464","volume":"6","author":"FR Day","year":"2015","unstructured":"Day FR, Hinds DA, Tung JY, Stolk L, Styrkarsdottir U, Saxena R et al (2015) Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun 6(1):8464. https:\/\/doi.org\/10.1038\/ncomms9464","journal-title":"Nat Commun"},{"issue":"1","key":"2512_CR50","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1038\/ncomms8502","volume":"6","author":"MG Hayes","year":"2015","unstructured":"Hayes MG, Urbanek M, Ehrmann DA, Armstrong LL, Lee JY, Sisk R et al (2015) Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun 6(1):7502. https:\/\/doi.org\/10.1038\/ncomms8502","journal-title":"Nat Commun"},{"issue":"1","key":"2512_CR51","doi-asserted-by":"publisher","first-page":"10479","DOI":"10.1038\/s41598-020-66633-2","volume":"10","author":"S-h Hong","year":"2020","unstructured":"Hong S-h, Hong YS, Jeong K, Chung H, Lee H, Sung Y-A (2020) Relationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes. Sci Rep 10(1):10479. https:\/\/doi.org\/10.1038\/s41598-020-66633-2","journal-title":"Sci Rep"},{"issue":"9","key":"2512_CR52","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ng.2384","volume":"44","author":"Y Shi","year":"2012","unstructured":"Shi Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z et al (2012) Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet 44(9):1020\u20131025. https:\/\/doi.org\/10.1038\/ng.2384","journal-title":"Nat Genet"},{"issue":"1","key":"2512_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ecl.2020.10.006","volume":"50","author":"CK Welt","year":"2021","unstructured":"Welt CK (2021) Genetics of polycystic ovary syndrome: what is new? Endocrinol Metab Clin North Am 50(1):71\u201382. https:\/\/doi.org\/10.1016\/j.ecl.2020.10.006","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"2512_CR54","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ajog.2020.04.004","volume":"223","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ho K, Keaton JM, Hartzel DN, Day F, Justice AE et al (2020) A genome-wide association study of polycystic ovary syndrome identified from electronic health records. Am J Obstet Gynecol 223(4):559. https:\/\/doi.org\/10.1016\/j.ajog.2020.04.004","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2512_CR55","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A, Martinell M, Dorkhan M, Carlsson A et al (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 6(5):361\u2013369. https:\/\/doi.org\/10.1016\/S2213-8587(18)30051-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"2512_CR56","doi-asserted-by":"publisher","first-page":"e1002654","DOI":"10.1371\/journal.pmed.1002654","volume":"15","author":"MS Udler","year":"2018","unstructured":"Udler MS, Kim J, von Grotthuss M, Bon\u00e0s-Guarch S, Cole JB, Chiou J et al (2018) Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis. PLoS Med 15(9):e1002654. https:\/\/doi.org\/10.1371\/journal.pmed.1002654","journal-title":"PLoS Med"},{"issue":"6","key":"2512_CR57","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas M, Dunaif A (2022) Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification. Endocr Rev 43(6):927\u2013965. https:\/\/doi.org\/10.1210\/endrev\/bnac001","journal-title":"Endocr Rev"},{"issue":"3","key":"2512_CR58","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2105\/ajph.41.3.279","volume":"41","author":"TR Dawber","year":"1951","unstructured":"Dawber TR, Meadors GF, Moore FE Jr (1951) Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 41(3):279\u2013286. https:\/\/doi.org\/10.2105\/ajph.41.3.279","journal-title":"Am J Public Health Nations Health"},{"issue":"9","key":"2512_CR59","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","volume":"19","author":"A Torkamani","year":"2018","unstructured":"Torkamani A, Wineinger NE, Topol EJ (2018) The personal and clinical utility of polygenic risk scores. Nat Rev Genet 19(9):581\u2013590. https:\/\/doi.org\/10.1038\/s41576-018-0018-x","journal-title":"Nat Rev Genet"},{"issue":"9","key":"2512_CR60","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera AV, Chaffin M, Aragam KG, Haas ME, Roselli C, Choi SH et al (2018) Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 50(9):1219\u20131224. https:\/\/doi.org\/10.1038\/s41588-018-0183-z","journal-title":"Nat Genet"},{"issue":"6","key":"2512_CR61","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1210\/clinem\/dgz326","volume":"105","author":"YY Joo","year":"2020","unstructured":"Joo YY, Actkins KE, Pacheco JA, Basile AO, Carroll R, Crosslin DR et al (2020) A polygenic and phenotypic risk prediction for polycystic ovary syndrome evaluated by phenome-wide association studies. J Clin Endocrinol Metab 105(6):1918\u20131936. https:\/\/doi.org\/10.1210\/clinem\/dgz326","journal-title":"J Clin Endocrinol Metab"},{"key":"2512_CR62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40618-017-0728-5","volume":"41","author":"R Cannarella","year":"2018","unstructured":"Cannarella R, Condorelli R, Mongio\u00ec L, La Vignera S, Calogero A (2018) Does a male polycystic ovarian syndrome equivalent exist? J Endocrinol Invest 41:49\u201357. https:\/\/doi.org\/10.1007\/s40618-017-0728-5","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2512_CR63","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2265.1993.tb02150.x","volume":"38","author":"A Carey","year":"1993","unstructured":"Carey A, Chan K, Short F, White D, Williamson R, Franks S (1993) Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol 38(6):653\u2013658. https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb02150.x","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2512_CR64","doi-asserted-by":"publisher","first-page":"79","DOI":"10.22074\/ijfs.2020.6092","volume":"14","author":"F Di Guardo","year":"2020","unstructured":"Di Guardo F, Ciotta L, Monteleone M, Palumbo M (2020) Male equivalent polycystic ovarian syndrome: hormonal, metabolic and clinical aspects. Int J Fertil Steril 14(2):79\u201383. https:\/\/doi.org\/10.22074\/ijfs.2020.6092","journal-title":"Int J Fertil Steril"},{"issue":"3","key":"2512_CR65","doi-asserted-by":"publisher","first-page":"287","DOI":"10.33549\/physiolres.930573","volume":"53","author":"M Du\u0161kov\u00e1","year":"2004","unstructured":"Du\u0161kov\u00e1 M, \u010cerm\u00e1kov\u00e1 I, Hill M, Va\u0148kov\u00e1 M, \u0160amal\u00edkov\u00e1 P, St\u00e1rka L (2004) What may be the markers of the male equivalent of polycystic ovary syndrome. Physiol Res 53(3):287\u2013294","journal-title":"Physiol Res"},{"issue":"1","key":"2512_CR66","first-page":"17","volume":"107","author":"M Du\u0161kov\u00e1","year":"2006","unstructured":"Du\u0161kov\u00e1 M, St\u00e1rka L (2006) The existence of a male equivalent of the polycystic ovary syndrome\u2013the present state of the issue. Prague Med Rep 107(1):17\u201325","journal-title":"Prague Med Rep"},{"key":"2512_CR67","first-page":"1307","volume":"13","author":"R Legro","year":"2000","unstructured":"Legro R (2000) Is there a male phenotype in polycystic ovary syndrome families? J Pediatr Endocrinol Metab 13:1307\u20131309","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"2512_CR68","first-page":"127","volume":"39","author":"L Starka","year":"2005","unstructured":"Starka L, Duskova M, Vrbikova J, Hill M (2005) Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome? Endocr Regul 39(4):127\u2013131","journal-title":"Endocr Regul"},{"issue":"4","key":"2512_CR69","doi-asserted-by":"publisher","first-page":"e1577","DOI":"10.1210\/clinem\/dgab838","volume":"107","author":"J Zhu","year":"2022","unstructured":"Zhu J, Pujol-Gualdo N, Wittemans LB, Lindgren CM, Laisk T, Hirschhorn JN et al (2022) Evidence from men for ovary-independent effects of genetic risk factors for polycystic ovary syndrome. J Clin Endocrinol Metab 107(4):e1577\u2013e1587. https:\/\/doi.org\/10.1210\/clinem\/dgab838","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2512_CR70","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41574-022-00636-z","volume":"18","author":"AE Joham","year":"2022","unstructured":"Joham AE, Teede HJ (2022) PCOS\u2014a metabolic condition with health impacts on women and men. Nat Rev Endocrinol 18(4):197\u2013198. https:\/\/doi.org\/10.1038\/s41574-022-00636-z","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"2512_CR71","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1001\/jamadermatol.2016.1776","volume":"152","author":"S Sanke","year":"2016","unstructured":"Sanke S, Chander R, Jain A, Garg T, Yadav P (2016) A comparison of the hormonal profile of early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women. JAMA Dermatol 152(9):986\u2013991. https:\/\/doi.org\/10.1001\/jamadermatol.2016.1776","journal-title":"JAMA Dermatol"},{"issue":"1","key":"2512_CR72","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1210\/jcem.84.1.5382","volume":"84","author":"A Govind","year":"1999","unstructured":"Govind A, Obhrai M, Clayton R (1999) Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 84(1):38\u201343. https:\/\/doi.org\/10.1210\/jcem.84.1.5382","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2512_CR73","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0015-0282(16)58687-7","volume":"66","author":"RJ Norman","year":"1996","unstructured":"Norman RJ, Masters S, Hague W (1996) Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. Fertil Ster 66(6):942\u2013947. https:\/\/doi.org\/10.1016\/S0015-0282(16)58687-7","journal-title":"Fertil Ster"},{"issue":"1","key":"2512_CR74","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clindermatol.2017.09.009","volume":"36","author":"C Lie","year":"2018","unstructured":"Lie C, Liew CF, Oon HH (2018) Alopecia and the metabolic syndrome. Clin Dermatol 36(1):54\u201361. https:\/\/doi.org\/10.1016\/j.clindermatol.2017.09.009","journal-title":"Clin Dermatol"},{"issue":"5","key":"2512_CR75","doi-asserted-by":"publisher","first-page":"e1010764","DOI":"10.1371\/journal.pgen.1010764","volume":"19","author":"KV Actkins","year":"2023","unstructured":"Actkins KV, Jean-Pierre G, Aldrich MC, Velez Edwards DR, Davis LK (2023) Sex modifies the effect of genetic risk scores for polycystic ovary syndrome on metabolic phenotypes. PLoS Genet 19(5):e1010764. https:\/\/doi.org\/10.1371\/journal.pgen.1010764","journal-title":"PLoS Genet"},{"key":"2512_CR76","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3389\/fendo.2020.00516","volume":"11","author":"A Aversa","year":"2020","unstructured":"Aversa A, La Vignera S, Rago R, Gambineri A, Nappi RE, Calogero AE et al (2020) Fundamental concepts and novel aspects of polycystic ovarian syndrome: expert consensus resolutions. Front Endocrinol 11:516. https:\/\/doi.org\/10.3389\/fendo.2020.00516","journal-title":"Front Endocrinol"},{"issue":"2","key":"2512_CR77","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nrendo.2015.230","volume":"12","author":"R Azziz","year":"2016","unstructured":"Azziz R (2016) New insights into the genetics of polycystic ovary syndrome. Nat Rev Endocrinol 12(2):74\u201375. https:\/\/doi.org\/10.1038\/nrendo.2015.230","journal-title":"Nat Rev Endocrinol"},{"issue":"7265","key":"2512_CR78","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nature08494","volume":"461","author":"TA Manolio","year":"2009","unstructured":"Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ et al (2009) Finding the missing heritability of complex diseases. Nature 461(7265):747\u2013753. https:\/\/doi.org\/10.1038\/nature08494","journal-title":"Nature"},{"issue":"5","key":"2512_CR79","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrg2344","volume":"9","author":"MI McCarthy","year":"2008","unstructured":"McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP et al (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9(5):356\u2013369. https:\/\/doi.org\/10.1038\/nrg2344","journal-title":"Nat Rev Genet"},{"key":"2512_CR80","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.coemr.2020.02.011","volume":"12","author":"M Dapas","year":"2020","unstructured":"Dapas M, Dunaif A (2020) The contribution of rare genetic variants to the pathogenesis of polycystic ovary syndrome. Curr Opin Endocr Metab Res 12:26\u201332. https:\/\/doi.org\/10.1016\/j.coemr.2020.02.011","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"7","key":"2512_CR81","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1210\/jc.2018-02178","volume":"104","author":"LK Gorsic","year":"2019","unstructured":"Gorsic LK, Dapas M, Legro RS, Hayes MG, Urbanek M (2019) Functional genetic variation in the anti-M\u00fcllerian hormone pathway in women with polycystic ovary syndrome. T J Clin Endocrinol Metab 104(7):2855\u20132874. https:\/\/doi.org\/10.1210\/jc.2018-02178","journal-title":"T J Clin Endocrinol Metab"},{"issue":"8","key":"2512_CR82","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1210\/jc.2017-00612","volume":"102","author":"LK Gorsic","year":"2017","unstructured":"Gorsic LK, Kosova G, Werstein B, Sisk R, Legro RS, Hayes MG et al (2017) Pathogenic anti-M\u00fcllerian hormone variants in polycystic ovary syndrome. J Clin Endocrinol Metab 102(8):2862\u20132872. https:\/\/doi.org\/10.1210\/jc.2017-00612","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2512_CR83","doi-asserted-by":"publisher","first-page":"bvac106","DOI":"10.1210\/jendso\/bvac106","volume":"6","author":"RP Crespo","year":"2022","unstructured":"Crespo RP, Rocha TP, Montenegro LR, Nishi MY, Jorge AAL, Maciel GAR et al (2022) High-throughput sequencing to identify monogenic etiologies in a preselected polycystic ovary syndrome cohort. J Endocr Soc 6(9):bvac106. https:\/\/doi.org\/10.1210\/jendso\/bvac106","journal-title":"J Endocr Soc"},{"issue":"9","key":"2512_CR84","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1210\/jc.2018-02496","volume":"104","author":"M Dapas","year":"2019","unstructured":"Dapas M, Sisk R, Legro RS, Urbanek M, Dunaif A, Hayes MG (2019) Family-based quantitative trait meta-analysis implicates rare noncoding variants in DENND1A in polycystic ovary syndrome. J Clin Endocrinol Metab 104(9):3835\u20133850. https:\/\/doi.org\/10.1210\/jc.2018-02496","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2512_CR85","doi-asserted-by":"publisher","first-page":"e12504","DOI":"10.1002\/rmb2.12504","volume":"22","author":"S Tamaoka","year":"2023","unstructured":"Tamaoka S, Saito K, Yoshida T, Nakabayashi K, Tatsumi K, Kawamura T et al (2023) Exome-based genome-wide screening of rare variants associated with the risk of polycystic ovary syndrome. Reprod Med Biol 22(1):e12504. https:\/\/doi.org\/10.1002\/rmb2.12504","journal-title":"Reprod Med Biol"},{"key":"2512_CR86","doi-asserted-by":"publisher","unstructured":"Tyrmi JS, Arffman RK, Pujol-Gualdo N, Kurra V, Morin-Papunen L, Sliz E et al (2022) Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome. Hum Reprod 2022;37(2):352\u2013365. https:\/\/doi.org\/10.1093\/humrep\/deab250","DOI":"10.1093\/humrep\/deab250"},{"issue":"2","key":"2512_CR87","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1086\/520599","volume":"81","author":"JT Salonen","year":"2007","unstructured":"Salonen JT, Uimari P, Aalto JM, Pirskanen M, Kaikkonen J, Todorova B et al (2007) Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am J Hum Genet 81(2):338\u2013345. https:\/\/doi.org\/10.1086\/520599","journal-title":"Am J Hum Genet"},{"issue":"7948","key":"2512_CR88","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-022-05684-z","volume":"614","author":"DJ Weiner","year":"2023","unstructured":"Weiner DJ, Nadig A, Jagadeesh KA, Dey KK, Neale BM, Robinson EB (2023) Polygenic architecture of rare coding variation across 394,783 exomes. Nature 614(7948):492\u2013499. https:\/\/doi.org\/10.1038\/s41586-022-05684-z","journal-title":"Nature"},{"key":"2512_CR89","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.semcdb.2015.04.007","volume":"43","author":"R Stegemann","year":"2015","unstructured":"Stegemann R, Buchner DA (2015) Transgenerational inheritance of metabolic disease. Semin Cell Dev Biol 43:131\u2013140. https:\/\/doi.org\/10.1016\/j.semcdb.2015.04.007","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"2512_CR90","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s43032-021-00515-4","volume":"29","author":"V Bruni","year":"2022","unstructured":"Bruni V, Capozzi A, Lello S (2022) The role of genetics, epigenetics and lifestyle in polycystic ovary syndrome development: the state of the art. Reprod Sci 29(3):668\u2013679. https:\/\/doi.org\/10.1007\/s43032-021-00515-4","journal-title":"Reprod Sci"},{"issue":"7","key":"2512_CR91","doi-asserted-by":"publisher","first-page":"936","DOI":"10.4239\/wjd.v6.i7.936","volume":"6","author":"EB Gur","year":"2015","unstructured":"Gur EB, Karadeniz M, Turan GA (2015) Fetal programming of polycystic ovary syndrome. World J Diabetes 6(7):936\u2013942. https:\/\/doi.org\/10.4239\/wjd.v6.i7.936","journal-title":"World J Diabetes"},{"issue":"2","key":"2512_CR92","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1210\/jc.2009-1849","volume":"95","author":"RS Legro","year":"2010","unstructured":"Legro RS, Roller RL, Dodson WC, Stetter CM, Kunselman AR, Dunaif A (2010) Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives. J Clin Endocrinol Metab 95(2):789\u2013799. https:\/\/doi.org\/10.1210\/jc.2009-1849","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2512_CR93","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/ajo.13420","volume":"61","author":"J Parker","year":"2021","unstructured":"Parker J, O\u2019Brien C, Gersh FL (2021) Developmental origins and transgenerational inheritance of polycystic ovary syndrome. Aust N Z J Obstet Gynaecol 61(6):922\u2013926. https:\/\/doi.org\/10.1111\/ajo.13420","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"3","key":"2512_CR94","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/ijerph19031336","volume":"19","author":"J Parker","year":"2022","unstructured":"Parker J, O\u2019brien C, Hawrelak J, Gersh FL (2022) Polycystic ovary syndrome: an evolutionary adaptation to lifestyle and the environment. Int J Environ Res Public Health 19(3):1336. https:\/\/doi.org\/10.3390\/ijerph19031336","journal-title":"Int J Environ Res Public Health"},{"key":"2512_CR95","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mce.2015.11.030","volume":"435","author":"M Puttabyatappa","year":"2016","unstructured":"Puttabyatappa M, Cardoso RC, Padmanabhan V (2016) Effect of maternal PCOS and PCOS-like phenotype on the offspring\u2019s health. Mol Cell Endocrinol 435:29\u201339. https:\/\/doi.org\/10.1016\/j.mce.2015.11.030","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2512_CR96","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1210\/jc.2005-2757","volume":"91","author":"N Xita","year":"2006","unstructured":"Xita N, Tsatsoulis A (2006) Fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 91(5):1660\u20131666. https:\/\/doi.org\/10.1210\/jc.2005-2757","journal-title":"J Clin Endocrinol Metab"},{"issue":"25","key":"2512_CR97","doi-asserted-by":"publisher","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","volume":"95","author":"RS Legro","year":"1998","unstructured":"Legro RS, Driscoll D, Strauss JF III, Fox J, Dunaif A (1998) Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A 95(25):14956\u201314960. https:\/\/doi.org\/10.1073\/pnas.95.25.14956","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2512_CR98","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2265.1990.tb03887.x","volume":"33","author":"WM Hague","year":"1990","unstructured":"Hague WM, Adams J, Rodda C, BROOK CG, DE BRUYN R, GRANT DB et al (1990) The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol 33(4):501\u2013510. https:\/\/doi.org\/10.1111\/j.1365-2265.1990.tb03887.x","journal-title":"Clin Endocrinol"},{"issue":"3","key":"2512_CR99","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2021.01.004","volume":"33","author":"NEH Mimouni","year":"2021","unstructured":"Mimouni NEH, Paiva I, Barbotin A-L, Timzoura FE, Plassard D, Le Gras S et al (2021) Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metab 33(3):513\u2013530e8. https:\/\/doi.org\/10.1016\/j.cmet.2021.01.004","journal-title":"Cell Metab"},{"issue":"12","key":"2512_CR100","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","volume":"25","author":"S Risal","year":"2019","unstructured":"Risal S, Pei Y, Lu H, Manti M, Fornes R, Pui H-P et al (2019) Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nat Med 25(12):1894\u20131904. https:\/\/doi.org\/10.1038\/s41591-019-0666-1","journal-title":"Nat Med"},{"issue":"6","key":"2512_CR101","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","volume":"24","author":"B Tata","year":"2018","unstructured":"Tata B, Mimouni NEH, Barbotin A-L, Malone SA, Loyens A, Pigny P et al (2018) Elevated prenatal anti-M\u00fcllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med 24(6):834\u2013846. https:\/\/doi.org\/10.1038\/s41591-018-0035-5","journal-title":"Nat Med"},{"key":"2512_CR102","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fendo.2020.00144","volume":"11","author":"H-L Zhang","year":"2020","unstructured":"Zhang H-L, Yi M, Li D, Li R, Zhao Y, Qiao J (2020) Transgenerational inheritance of reproductive and metabolic phenotypes in PCOS rats. Front Endocrinol 11:144. https:\/\/doi.org\/10.3389\/fendo.2020.00144","journal-title":"Front Endocrinol"},{"issue":"12","key":"2512_CR103","doi-asserted-by":"publisher","first-page":"bqac164","DOI":"10.1210\/endocr\/bqac164","volume":"163","author":"E Stener-Victorin","year":"2022","unstructured":"Stener-Victorin E (2022) Update on animal models of polycystic ovary syndrome. Endocrinology 163(12):bqac164. https:\/\/doi.org\/10.1210\/endocr\/bqac164","journal-title":"Endocrinology"},{"issue":"6","key":"2512_CR104","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/biomedicines10061291","volume":"10","author":"KJ Siemienowicz","year":"2022","unstructured":"Siemienowicz KJ, Filis P, Thomas J, Fowler PA, Duncan WC, Rae MT (2022) Hepatic mitochondrial dysfunction and risk of Liver Disease in an ovine model of PCOS males. Biomedicines 10(6):1291. https:\/\/doi.org\/10.3390\/biomedicines10061291","journal-title":"Biomedicines"},{"issue":"2","key":"2512_CR105","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1172\/JCI118126","volume":"96","author":"A Dunaif","year":"1995","unstructured":"Dunaif A, Xia J, Book CB, Schenker E, Tang Z (1995) Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 96(2):801\u2013810. https:\/\/doi.org\/10.1172\/JCI118126","journal-title":"J Clin Invest"},{"issue":"1","key":"2512_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-11-228","volume":"11","author":"MK Skinner","year":"2013","unstructured":"Skinner MK, Manikkam M, Tracey R, Guerrero-Bosagna C, Haque M, Nilsson EE (2013) Ancestral dichlorodiphenyltrichloroethane (DDT) exposure promotes epigenetic transgenerational inheritance of obesity. BMC Med 11(1):1\u201316. https:\/\/doi.org\/10.1186\/1741-7015-11-228","journal-title":"BMC Med"},{"issue":"1","key":"2512_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-11-29","volume":"11","author":"A Soubry","year":"2013","unstructured":"Soubry A, Schildkraut JM, Murtha A, Wang F, Huang Z, Bernal A et al (2013) Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn epigenetics Study (NEST) cohort. BMC Med 11(1):1\u201310. https:\/\/doi.org\/10.1186\/1741-7015-11-29","journal-title":"BMC Med"},{"issue":"12","key":"2512_CR108","doi-asserted-by":"publisher","first-page":"e12480","DOI":"10.1016\/j.heliyon.2022.e12480","volume":"8","author":"MA Hossain","year":"2022","unstructured":"Hossain MA, Al Ashik SA, Mahin MR, Al Amin M, Rahman MH, Khan MA, Al Emran A (2022) Systems biology and in silico-based analysis of PCOS revealed the risk of metabolic disorders. Heliyon 8(12):e12480. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12480","journal-title":"Heliyon"},{"key":"2512_CR109","doi-asserted-by":"publisher","first-page":"905716","DOI":"10.3389\/fgene.2022.905716","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Xiao H, Yujia M, Zhou Z, Chen D (2022) Identifying novel genetic loci associated with polycystic ovary syndrome based on its shared genetic architecture with type 2 diabetes. Front Genet 13:905716. https:\/\/doi.org\/10.3389\/fgene.2022.905716","journal-title":"Front Genet"},{"issue":"1","key":"2512_CR110","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12916-022-02238-y","volume":"20","author":"Q Liu","year":"2022","unstructured":"Liu Q, Zhu Z, Kraft P, Deng Q, Stener-Victorin E, Jiang X (2022) Genomic correlation, shared loci, and causal relationship between obesity and polycystic ovary syndrome: a large-scale genome-wide cross-trait analysis. BMC Med 20(1):66. https:\/\/doi.org\/10.1186\/s12916-022-02238-y","journal-title":"BMC Med"},{"key":"2512_CR111","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1477-7827-11-56","volume":"11","author":"JZ Qin","year":"2013","unstructured":"Qin JZ, Pang LH, Li MJ, Fan XJ, Huang RD, Chen HY (2013) Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol 11:56. https:\/\/doi.org\/10.1186\/1477-7827-11-56","journal-title":"Reprod Biol Endocrinol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02512-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02512-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02512-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T04:48:43Z","timestamp":1743310123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02512-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":111,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["2512"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02512-1","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]},"assertion":[{"value":"30 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}